Financials in USD. Standardized financial statements.
A compact view of how CuraScientific Corp turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Revenue? | $34,434 | $86,259 | $60,157 | $81,456 | $85,652 | $238,988 |
| Revenue Growth? | -60.1% | +43.4% | -26.1% | -4.9% | -64.2% | 0.0% |
| Cost of Revenue? | $1.17M | $30,946 | $18,441 | $26,514 | $29,195 | $209,728 |
| Gross Profit? | -$1.14M | $55,313 | $41,716 | $54,942 | $56,457 | $29,260 |
| Gross Margin? | -3298.1% | +64.1% | +69.3% | +67.4% | +65.9% | +12.2% |
| Operating Expenses? | $1.24M | $4.83M | $2.57M | $52,036 | $45,579 | $3,880 |
| Operating Income? | -$2.38M | -$4.78M | -$2.53M | $2,910 | $10,880 | $25,380 |
| EBITDA? | -$3.43M | -$4.10M | -$4.11M | $13,906 | $21,880 | $25,380 |
| Income Before Tax | -$5.27M | -$5.87M | -$4.86M | -$10,664 | -$796 | $25,380 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$5.27M | -$5.87M | -$4.86M | -$10,664 | -$796 | $25,380 |
| EPS? | $-1.11 | $-19.32 | $-82.40 | $-17.39 | $-1.30 | $41.59 |
| Diluted EPS? | $-1.11 | $-19.32 | $-82.40 | $-17.39 | $-1.30 | $41.59 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality